[1] | Figueiredo, E.L., Machado, F.P. Digoxin's roles in heart failure patients: An overview. Cardiology. 5 (5): 59-64, 2010. |
|
[2] | Winter, M.L. Basic clinical pharmacokinetics. Philadelphia, Lippincott Williams & Wilkins, 2004. |
|
[3] | DiPiro J.T et al. Pharmacotherapy A pathophysiologic approach, seven edition McGraw HILL, 2008. |
|
[4] | Duhme D.W.,, Greenblatt D. J., Koch-Weser J. Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborate Drug Surveillance Program. Ann Inter Med, 80: 516-519, 1974. |
|
[5] | Dobbs R.J., Nicholson P.W., Dobbs S.M., O'Neill C.J. Therapeutic drug monitoring of digoxin: Helper or hinders?. Eur. J. clin. Pharmacol. 31:491-5, 1986. |
|
[6] | Sidwell A., Barclay M., Begg E., Moore G. Digoxin therapeutic monitoring: an audit and review. The New Zeland Medical Journal, 116 (1187):1-6, 2003. |
|
[7] | Farid S. F, Abbassia M.M, Sabrya N.A., Abdl Elkhaeq. Evaluation of digoxin in two Egyptian hospitals A pilot study. Austaralian Journal of basic and applied Sciences, 3(3):1838-1841, 2009. |
|
[8] | Aronson J.K, Hardman M. ABC of monitoring drug therapy. Digoxin. BMJ, 305: 1149-52, 1992. |
|
[9] | Kumana CR, Chan YM, Kou M. Audit exposes flawed blood sampling for “digoxin levels”. Ther Drug Monit, 14: 155-8, 1992. |
|
[10] | Williamson KM, Thrasher KA, Fulton KB, et al. Digoxin toxicity: an evaluation in current clinical practice. Arch Intern Med, 158: 2444-9, 1998. |
|
[11] | Smith TW, Haber E. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J Clin Invest, 49: 2377-86, 1970. |
|
[12] | Canas F, Tanasijevic MJ, Ma’luf N, Bates DW. Evaluating the appropriateness of digoxin level monitoring. Arch Intern Med, 159: 363-8, 1999. |
|
[13] | Copeland RJ, Thorpe H, Kay EA. Inappropriate digoxin monitoring.J Clin Pharm Ther. 17:173-4, 1992. |
|
[14] | Slaughter RL, Schneider PJ, Visconti JA. Appropriateness of the use of serum digoxin and digitoxin assays. Am J Hosp Pharm, 35: 1376-9. 1978. |
|
[15] | Mordasini M.R., Krabenbublr S., Schlienger R. G. Appropriateness of digoxin level monitoring. SWISS MED WKLY, 132: 506-512, 2002. |
|
[16] | Orrico K. B., Wu. M., Wilson A. R. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting. Journal of Managed Care Pharmacy, 17(9): 695-700.2011. |
|
[17] | Jessup M., Abraham WT., Casy DE, et al 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation, 119: 1977-2016. 2009. |
|
[18] | Nagaraja N.V, Park Y.J, Jeon S, Sands C.D, Derendorf H. Population pharmacokinetics of digoxin in Korean patients. Int J Clin Pharmacol Ther. 38(6):291-7, 2000. |
|
[19] | Zhou X.D, Gao Y, Guan Z, Li ZD, Li J. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice. Acta Pharmacol Sin., 31(6):753-8, 2010. |
|
[20] | Xiao-dan Zhou, Yan Gao, Zheng Guan, Zhong-dong Li and Jun Li. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice. Acta Pharmacologica Sinica, 31: 753-758. 2010. |
|
[21] | EL Desoky, E.S. Nagaraja, Nelamangala V.2; Derendorf, Hartmut. Population Pharmacokinetics of Digoxin in Egyptian Pediatric Patients: Impact of One Data Point Utilization. American Journal of Therapeutics: 9(6), 492-498. 2002. |
|
[22] | Yukawa, E., Suematu, F.; Yukawa, M., Minemoto, M., Ohdo, S., Higuchi, S., Goto, Y., Aoyama, T. Population Pharmacokinetics of Digoxin in Japanese Patients: A 2-Compartment Pharmacokinetic Model. Clinical Pharmacokinetics, 40 (10), 773-781. 2001. |
|
[23] | Cockcroft, D. & Gault, M., Prediction of creatinine clearance from serum creatinine. Nephron. 16, 31-41. 1976. |
|
[24] | Ansel, H. & Prince, S. Pharmaceutical calculations: the pharmacist’s handbook. 1st Ed. United States of America: Lippincott Williams & Wilkins, 2004. |
|
[25] | Bauer, L.A., Applied Clinical Pharmacokinetics. 1st Ed. United States of America: McGraw-Hill Professional. 2001. |
|
[26] | Hornestam, B. & Karlsson, M., Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial. Eur J Clin Pharmacol 58.P.PP. 747-755, 2003. |
|
[27] | Liu, D., Stay Healthy, Live Longer, Spend Wisely: Making Intelligent Choices inAmerica’s Healthcare System. 1st Ed. United States of America: Stetho Publishing, 2008. |
|
[28] | Fong, B., Fong, A.C.M. & Li, C.K., Telemedicine Technologies: Information Technologies in Medicine and Telehealth. 1st Ed. india: John Wiley and Sons, 2011. |
|
[29] | Goroll, A. & Mulley, A., Primary Care Medicine: Office EvaluationAnd Management of The AdultPatient. 6th Ed. china: Lippincott Williams & Wilkins. 2009. |
|
[30] | Ford, S.M. & Roach, S.S., Roach’s Introductory Clinical Pharmacology. 9th Ed. London: Lippincott Williams & Wilkins. 2009. |
|
[31] | Burke, M., Wilkes, G. & Ingwersen, K., Cancer Chemotherapy: a nursing process approach. 3rd Ed. United States of America: Jones & Bartlett Learning, 2001. |
|
[32] | Ferrari, S.J., Bestetti, R.B., Cardinalli-neto, A. & Bortoluzzi, T.B., Article / Artigo Digoxin serum levels in patients with Chagas ’ cardiomyopathy and heart failure Níveis séricos de digoxina em pacientes com insuficiência cardíaca secundária à cardiomiopatia da doença de Chagas. Revista da Sociedade Brasileira de Medicina Tropical. 43 (5). 496-499. 2010. |
|
[33] | Rich, M.W., McSherry, F., Williford, W.O. & Yusuf, S., Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. Journal of the American College of Cardiology. 38 (3). 806-13. 2001. |
|
[34] | Baylis, E.M., Hall, M.S., Lewis, G. & Marks, V., Effects of renal function on plasma digoxin levels in elderly ambulant patients in domiciliary practice. British medical journal. 1 (5796). 338-41. 1972. |
|
[35] | Abernethy, D., Greenblatt, D. & Smith, T. (1981a). Digoxin disposition in obesity: Clinical pharmacokinetic investigation. American Heart Journal. 102, 740-744. 1981. |
|
[36] | Hosenpud, J.D. & Greenberg, B.H., Congestive Heart Failure. 3rd Ed. United States of America: Lippincott Williams & Wilkins, 2007. |
|